retatrutide updates Retatrutide: The first-in-class investigational triple receptor agonist redefining Type 2 diabetes therapy Retatrutide FDA Approval Guide: Process

Wegovy begins working from the first injection by mimicking natural appetite-regulating hormones, helping reduce hunger and increase feelings of fullness

We do not have a definitive answer yet

Post-discontinuation, 19.6 % restarted the original medication, while 35 % adopted another option: alternative medication (27.4 %), healthcare visit for lifestyle modification (13.7 %), and metabolic and bariatric surgery (0.6 %)

References Eli Lilly and Company

(2020) 8:e00644

Despite lots of big lingering questions, many clinicians dont think it actually matters right now how GLP-1 interacts with brain receptors on a cellular level, says Laura Huckins, PhD, an associate professor of psychiatry at the Yale School of Medicine